Cytokines released in patients with bladder cancer treated with BCG include TRAIL (TNF-related apoptosis-inducing ligand), IL-2, IL-8, IL-18, IL-12, IFN-γ, and TNFα (66). The gene discussed is IL2; the disease is urinary bladder carcinoma.